Over the long term, treatment with radiation plus tamoxifen for early-stage breast cancer has a small benefit in locoregional recurrence.
Xgeva (denosumab; Amgen) has been approved for the treatment of unresectable giant cell tumor of the bone (GCTB) in adult and adolescent patients.
Replacement of 10% of carbohydrates with vegetable fat cuts the incidence of lethal prostate cancer and death from the disease.
The incidence of melanoma in adolescents and children is small but growing, and the reasons are obscure.
Recent studies document economic and racial disparities in access to breast cancer care, with impacts on outcomes for poor and minority women.
DC, a 54-year-old male diagnosed with multiple myeloma, develops a low grade fever and some mild diarrhea 10 days ...
AG, 64-year-old gentleman of Greek descent, presents with a 6-month history of rash that started on his upper extremities ...
Tara Morrison, MD, Advisory Board member, shares the case of a 66-year-old African American man with weight loss and pain around the abdomen.
Advisory Board member Martin S. Tallman, MD, shares the unusual case of a patient with pancytopenia.
Barbara Ann Burtness, MD
Steven Cohen, MD
E. David Crawford, MD
Jeffrey M. Farma, MD
Eric Feldman, MD
Sergio A. Giralt, MD
Todd Morgan, MD
Edith A. Perez, MD
Neal D. Shore, MD, FACS
Mark A. Socinski, MD
Martin Tallman, MD
Adelle Berezinsky, PharmD
Kimberly A. Bracey, MBA/MSN/HCM, OCN
Inez Brandon, MSN
Sandra Cuellar, PharmD, BCOP
Jeanne Held-Warmkessel, MSN
Anna Hitron, PharmD, MS, BCOP
Thomas P. Lynch, Jr. BSPharm, BCOP
Ali McBride, MS, PharmD
Ayman Saad, MD
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|